Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $1.06 in the prior trading day, Heron Therapeutics Inc (NASDAQ: HRTX) closed at $1.07, up 0.94%. In other words, the price has increased by $0.94 from its previous closing price. On the day, 1.34 million shares were traded. HRTX stock price reached its highest trading level at $1.1 during the session, while it also had its lowest trading level at $1.06.
Ratios:
Our goal is to gain a better understanding of HRTX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.74 and its Current Ratio is at 2.28.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on June 13, 2024, initiated with a Buy rating and assigned the stock a target price of $7.
On April 23, 2024, CapitalOne started tracking the stock assigning a Overweight rating and target price of $6.
Needham reiterated its Buy rating for the stock on March 13, 2024, while the target price for the stock was revised from $4 to $5.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HRTX now has a Market Capitalization of 162741664 and an Enterprise Value of 270097568. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.19. Its current Enterprise Value per Revenue stands at 1.961 whereas that against EBITDA is -47.427.
Stock Price History:
Over the past 52 weeks, HRTX has reached a high of $3.93, while it has fallen to a 52-week low of $1.04. The 50-Day Moving Average of the stock is -38.93%, while the 200-Day Moving Average is calculated to be -57.65%.
Shares Statistics:
The stock has traded on average 1.81M shares per day over the past 3-months and 2824370 shares per day over the last 10 days, according to various share statistics. A total of 152.09M shares are outstanding, with a floating share count of 151.01M. Insiders hold about 0.71% of the company’s shares, while institutions hold 80.23% stake in the company. Shares short for HRTX as of 1730332800 were 28810535 with a Short Ratio of 15.88, compared to 1727654400 on 31703092. Therefore, it implies a Short% of Shares Outstanding of 28810535 and a Short% of Float of 24.560000000000002.
